MEPs are divided over EU rules on new types of treatment for diseases such as cancer or Alzheimer's, with conservative deputies calling for safeguards against medicines developed through embryonic stem cell research, a practice that is illegal in some countries.
After a series of delays, the European Parliament is set to vote on Wednesday (25 April) on the new EU regulation on so called "advanced therapies" - gene therapy, adult stem cell therapy and tissue engineering.
All three...
Back our independent journalism by becoming a supporting member
Already a member? Login here